Use of triple and quadruple neurohormonal blockade in heart failure: new data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM)-Added trial
Publication
, Conference
Weir, RAP; Mcmurray, JJV; Granger, CB; Puu, M; Ostergren, J; Yusuf, S; Swedberg, K; Pfeffer, MA
Published in: EUROPEAN HEART JOURNAL
August 1, 2006
Duke Scholars
Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
August 1, 2006
Volume
27
Start / End Page
331 / 331
Location
Barcelona, SPAIN
Publisher
OXFORD UNIV PRESS
Conference Name
28th Congress of the European-Society-of-Cardiology/World Congress of Cardiology
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Weir, R. A. P., Mcmurray, J. J. V., Granger, C. B., Puu, M., Ostergren, J., Yusuf, S., … Pfeffer, M. A. (2006). Use of triple and quadruple neurohormonal blockade in heart failure: new data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM)-Added trial. In EUROPEAN HEART JOURNAL (Vol. 27, pp. 331–331). Barcelona, SPAIN: OXFORD UNIV PRESS.
Weir, R. A. P., J. J. V. Mcmurray, C. B. Granger, M. Puu, J. Ostergren, S. Yusuf, K. Swedberg, and M. A. Pfeffer. “Use of triple and quadruple neurohormonal blockade in heart failure: new data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM)-Added trial.” In EUROPEAN HEART JOURNAL, 27:331–331. OXFORD UNIV PRESS, 2006.
Weir RAP, Mcmurray JJV, Granger CB, Puu M, Ostergren J, Yusuf S, et al. Use of triple and quadruple neurohormonal blockade in heart failure: new data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM)-Added trial. In: EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2006. p. 331–331.
Weir, R. A. P., et al. “Use of triple and quadruple neurohormonal blockade in heart failure: new data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM)-Added trial.” EUROPEAN HEART JOURNAL, vol. 27, OXFORD UNIV PRESS, 2006, pp. 331–331.
Weir RAP, Mcmurray JJV, Granger CB, Puu M, Ostergren J, Yusuf S, Swedberg K, Pfeffer MA. Use of triple and quadruple neurohormonal blockade in heart failure: new data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM)-Added trial. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2006. p. 331–331.
Published In
EUROPEAN HEART JOURNAL
EISSN
1522-9645
ISSN
0195-668X
Publication Date
August 1, 2006
Volume
27
Start / End Page
331 / 331
Location
Barcelona, SPAIN
Publisher
OXFORD UNIV PRESS
Conference Name
28th Congress of the European-Society-of-Cardiology/World Congress of Cardiology
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology